Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Inventory (2019 - 2025)

Eton Pharmaceuticals' Inventory history spans 7 years, with the latest figure at $15.4 million for Q4 2025.

  • On a quarterly basis, Inventory rose 1.23% to $15.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.4 million, a 1.23% increase, with the full-year FY2025 number at $15.4 million, up 1.23% from a year prior.
  • Inventory hit $15.4 million in Q4 2025 for Eton Pharmaceuticals, down from $16.9 million in the prior quarter.
  • Over the last five years, Inventory for ETON hit a ceiling of $23.8 million in Q2 2025 and a floor of $334000.0 in Q3 2021.
  • Historically, Inventory has averaged $5.0 million across 5 years, with a median of $1.1 million in 2021.
  • Biggest five-year swings in Inventory: tumbled 80.34% in 2021 and later skyrocketed 1572.01% in 2024.
  • Tracing ETON's Inventory over 5 years: stood at $550000.0 in 2021, then grew by 1.27% to $557000.0 in 2022, then skyrocketed by 63.55% to $911000.0 in 2023, then skyrocketed by 1572.01% to $15.2 million in 2024, then grew by 1.23% to $15.4 million in 2025.
  • Business Quant data shows Inventory for ETON at $15.4 million in Q4 2025, $16.9 million in Q3 2025, and $23.8 million in Q2 2025.